nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Niclosamide—STAT3—head and neck cancer	0.074	0.921	CrCbGaD
Tolcapone—Leukaemia—Hydroxyurea—head and neck cancer	0.0361	0.0393	CcSEcCtD
Tolcapone—Ovarian cancer—Docetaxel—head and neck cancer	0.0291	0.0317	CcSEcCtD
Tolcapone—Lacrimal structural disorder—Docetaxel—head and neck cancer	0.0172	0.0187	CcSEcCtD
Tolcapone—Pericardial effusion—Docetaxel—head and neck cancer	0.0123	0.0134	CcSEcCtD
Tolcapone—Cellulitis—Vinblastine—head and neck cancer	0.0117	0.0127	CcSEcCtD
Tolcapone—Lacrimal disorder—Docetaxel—head and neck cancer	0.0113	0.0123	CcSEcCtD
Tolcapone—Encephalopathy—Fluorouracil—head and neck cancer	0.0109	0.0119	CcSEcCtD
Tolcapone—Duodenal ulcer—Docetaxel—head and neck cancer	0.0105	0.0114	CcSEcCtD
Tolcapone—Neoplasm—Vinblastine—head and neck cancer	0.00964	0.0105	CcSEcCtD
Tolcapone—Neoplasm—Hydroxyurea—head and neck cancer	0.00879	0.00956	CcSEcCtD
Tolcapone—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00871	0.00947	CcSEcCtD
Tolcapone—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00866	0.00941	CcSEcCtD
Tolcapone—Speech disorder—Fluorouracil—head and neck cancer	0.00814	0.00885	CcSEcCtD
Tolcapone—Cerebrovascular accident—Vinblastine—head and neck cancer	0.0079	0.00859	CcSEcCtD
Tolcapone—Parosmia—Docetaxel—head and neck cancer	0.00779	0.00847	CcSEcCtD
Tolcapone—Cellulitis—Fluorouracil—head and neck cancer	0.0077	0.00837	CcSEcCtD
Tolcapone—Herpes simplex—Fluorouracil—head and neck cancer	0.00759	0.00826	CcSEcCtD
Tolcapone—Neuralgia—Docetaxel—head and neck cancer	0.00727	0.00791	CcSEcCtD
Tolcapone—Face oedema—Hydroxyurea—head and neck cancer	0.00681	0.00741	CcSEcCtD
Tolcapone—Angina pectoris—Vinblastine—head and neck cancer	0.00652	0.00709	CcSEcCtD
Tolcapone—Otitis media—Docetaxel—head and neck cancer	0.00649	0.00706	CcSEcCtD
Tolcapone—Oesophagitis—Fluorouracil—head and neck cancer	0.0064	0.00695	CcSEcCtD
Tolcapone—Tolmetin—PTGS2—head and neck cancer	0.00634	0.0789	CrCbGaD
Tolcapone—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00628	0.00683	CcSEcCtD
Tolcapone—Euphoric mood—Fluorouracil—head and neck cancer	0.00601	0.00654	CcSEcCtD
Tolcapone—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00588	0.00639	CcSEcCtD
Tolcapone—Myocardial infarction—Vinblastine—head and neck cancer	0.00585	0.00636	CcSEcCtD
Tolcapone—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00585	0.00636	CcSEcCtD
Tolcapone—Chest discomfort—Docetaxel—head and neck cancer	0.00571	0.00621	CcSEcCtD
Tolcapone—Dysuria—Hydroxyurea—head and neck cancer	0.0057	0.0062	CcSEcCtD
Tolcapone—Oliguria—Docetaxel—head and neck cancer	0.00548	0.00596	CcSEcCtD
Tolcapone—Infestation NOS—Hydroxyurea—head and neck cancer	0.00544	0.00591	CcSEcCtD
Tolcapone—Infestation—Hydroxyurea—head and neck cancer	0.00544	0.00591	CcSEcCtD
Tolcapone—Amnesia—Fluorouracil—head and neck cancer	0.00541	0.00588	CcSEcCtD
Tolcapone—Haemoglobin—Vinblastine—head and neck cancer	0.00538	0.00585	CcSEcCtD
Tolcapone—Haemorrhage—Vinblastine—head and neck cancer	0.00535	0.00582	CcSEcCtD
Tolcapone—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00533	0.0058	CcSEcCtD
Tolcapone—Hypoaesthesia—Vinblastine—head and neck cancer	0.00533	0.00579	CcSEcCtD
Tolcapone—Pharyngitis—Vinblastine—head and neck cancer	0.00531	0.00578	CcSEcCtD
Tolcapone—Stomatitis—Hydroxyurea—head and neck cancer	0.0053	0.00577	CcSEcCtD
Tolcapone—Cardiac failure—Fluorouracil—head and neck cancer	0.00521	0.00566	CcSEcCtD
Tolcapone—Lethargy—Fluorouracil—head and neck cancer	0.00518	0.00564	CcSEcCtD
Tolcapone—Osteoarthritis—Fluorouracil—head and neck cancer	0.00508	0.00552	CcSEcCtD
Tolcapone—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00508	0.00552	CcSEcCtD
Tolcapone—Pulmonary embolism—Docetaxel—head and neck cancer	0.00505	0.00549	CcSEcCtD
Tolcapone—Hepatocellular injury—Docetaxel—head and neck cancer	0.00505	0.00549	CcSEcCtD
Tolcapone—Haemoglobin—Hydroxyurea—head and neck cancer	0.00491	0.00534	CcSEcCtD
Tolcapone—Haemorrhage—Hydroxyurea—head and neck cancer	0.00488	0.00531	CcSEcCtD
Tolcapone—Hallucination—Hydroxyurea—head and neck cancer	0.00486	0.00528	CcSEcCtD
Tolcapone—Colitis—Docetaxel—head and neck cancer	0.00485	0.00527	CcSEcCtD
Tolcapone—Irritability—Fluorouracil—head and neck cancer	0.00485	0.00527	CcSEcCtD
Tolcapone—Cardiac arrest—Fluorouracil—head and neck cancer	0.00483	0.00525	CcSEcCtD
Tolcapone—Neuropathy—Docetaxel—head and neck cancer	0.00474	0.00516	CcSEcCtD
Tolcapone—Alopecia—Vinblastine—head and neck cancer	0.00473	0.00514	CcSEcCtD
Tolcapone—Oesophagitis—Docetaxel—head and neck cancer	0.00462	0.00502	CcSEcCtD
Tolcapone—Neoplasm—Docetaxel—head and neck cancer	0.00457	0.00497	CcSEcCtD
Tolcapone—Pulmonary oedema—Docetaxel—head and neck cancer	0.0045	0.00489	CcSEcCtD
Tolcapone—Angiopathy—Hydroxyurea—head and neck cancer	0.00443	0.00482	CcSEcCtD
Tolcapone—Dysphagia—Fluorouracil—head and neck cancer	0.00439	0.00477	CcSEcCtD
Tolcapone—Chills—Hydroxyurea—head and neck cancer	0.00438	0.00476	CcSEcCtD
Tolcapone—Ill-defined disorder—Vinblastine—head and neck cancer	0.00432	0.0047	CcSEcCtD
Tolcapone—Alopecia—Hydroxyurea—head and neck cancer	0.00431	0.00469	CcSEcCtD
Tolcapone—Anaemia—Vinblastine—head and neck cancer	0.00431	0.00468	CcSEcCtD
Tolcapone—Angina pectoris—Fluorouracil—head and neck cancer	0.00428	0.00465	CcSEcCtD
Tolcapone—Malaise—Vinblastine—head and neck cancer	0.0042	0.00457	CcSEcCtD
Tolcapone—Vertigo—Vinblastine—head and neck cancer	0.00419	0.00455	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00408	0.00444	CcSEcCtD
Tolcapone—Hypertension—Vinblastine—head and neck cancer	0.00402	0.00438	CcSEcCtD
Tolcapone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00394	0.00429	CcSEcCtD
Tolcapone—Pneumonia—Fluorouracil—head and neck cancer	0.00394	0.00428	CcSEcCtD
Tolcapone—Anaemia—Hydroxyurea—head and neck cancer	0.00393	0.00427	CcSEcCtD
Tolcapone—Discomfort—Vinblastine—head and neck cancer	0.00392	0.00426	CcSEcCtD
Tolcapone—Infestation NOS—Fluorouracil—head and neck cancer	0.00392	0.00426	CcSEcCtD
Tolcapone—Infestation—Fluorouracil—head and neck cancer	0.00392	0.00426	CcSEcCtD
Tolcapone—Atrial fibrillation—Docetaxel—head and neck cancer	0.00387	0.00421	CcSEcCtD
Tolcapone—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00386	0.0042	CcSEcCtD
Tolcapone—Myocardial infarction—Fluorouracil—head and neck cancer	0.00384	0.00417	CcSEcCtD
Tolcapone—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00384	0.00417	CcSEcCtD
Tolcapone—Malaise—Hydroxyurea—head and neck cancer	0.00383	0.00417	CcSEcCtD
Tolcapone—Stomatitis—Fluorouracil—head and neck cancer	0.00382	0.00415	CcSEcCtD
Tolcapone—Urinary tract infection—Fluorouracil—head and neck cancer	0.00381	0.00414	CcSEcCtD
Tolcapone—Cardiac failure—Docetaxel—head and neck cancer	0.00376	0.00409	CcSEcCtD
Tolcapone—Lethargy—Docetaxel—head and neck cancer	0.00374	0.00407	CcSEcCtD
Tolcapone—Thrombocytopenia—Vinblastine—head and neck cancer	0.00372	0.00405	CcSEcCtD
Tolcapone—Epistaxis—Fluorouracil—head and neck cancer	0.00369	0.00402	CcSEcCtD
Tolcapone—Sinusitis—Fluorouracil—head and neck cancer	0.00367	0.00399	CcSEcCtD
Tolcapone—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00367	0.00399	CcSEcCtD
Tolcapone—Anorexia—Vinblastine—head and neck cancer	0.00363	0.00394	CcSEcCtD
Tolcapone—Migraine—Docetaxel—head and neck cancer	0.00361	0.00392	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00359	0.00391	CcSEcCtD
Tolcapone—Discomfort—Hydroxyurea—head and neck cancer	0.00358	0.00389	CcSEcCtD
Tolcapone—Haemoglobin—Fluorouracil—head and neck cancer	0.00353	0.00384	CcSEcCtD
Tolcapone—Rhinitis—Fluorouracil—head and neck cancer	0.00352	0.00383	CcSEcCtD
Tolcapone—Haemorrhage—Fluorouracil—head and neck cancer	0.00351	0.00382	CcSEcCtD
Tolcapone—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0035	0.0038	CcSEcCtD
Tolcapone—Pharyngitis—Fluorouracil—head and neck cancer	0.00349	0.00379	CcSEcCtD
Tolcapone—Oedema—Hydroxyurea—head and neck cancer	0.00347	0.00377	CcSEcCtD
Tolcapone—Infection—Hydroxyurea—head and neck cancer	0.00345	0.00375	CcSEcCtD
Tolcapone—Paraesthesia—Vinblastine—head and neck cancer	0.00342	0.00371	CcSEcCtD
Tolcapone—Dehydration—Docetaxel—head and neck cancer	0.00341	0.00371	CcSEcCtD
Tolcapone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.0034	0.0037	CcSEcCtD
Tolcapone—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0034	0.00369	CcSEcCtD
Tolcapone—Skin disorder—Hydroxyurea—head and neck cancer	0.00337	0.00366	CcSEcCtD
Tolcapone—Anorexia—Hydroxyurea—head and neck cancer	0.00331	0.0036	CcSEcCtD
Tolcapone—Decreased appetite—Vinblastine—head and neck cancer	0.00331	0.0036	CcSEcCtD
Tolcapone—Cramp muscle—Docetaxel—head and neck cancer	0.0033	0.00359	CcSEcCtD
Tolcapone—Constipation—Vinblastine—head and neck cancer	0.00325	0.00354	CcSEcCtD
Tolcapone—Pain—Vinblastine—head and neck cancer	0.00325	0.00354	CcSEcCtD
Tolcapone—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00323	0.00352	CcSEcCtD
Tolcapone—Dysphagia—Docetaxel—head and neck cancer	0.00317	0.00345	CcSEcCtD
Tolcapone—Arrhythmia—Fluorouracil—head and neck cancer	0.00314	0.00341	CcSEcCtD
Tolcapone—Feeling abnormal—Vinblastine—head and neck cancer	0.00313	0.00341	CcSEcCtD
Tolcapone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00311	0.00338	CcSEcCtD
Tolcapone—Alopecia—Fluorouracil—head and neck cancer	0.00311	0.00338	CcSEcCtD
Tolcapone—Dyspnoea—Hydroxyurea—head and neck cancer	0.00309	0.00336	CcSEcCtD
Tolcapone—Angina pectoris—Docetaxel—head and neck cancer	0.00309	0.00336	CcSEcCtD
Tolcapone—Somnolence—Hydroxyurea—head and neck cancer	0.00308	0.00335	CcSEcCtD
Tolcapone—Dyspepsia—Hydroxyurea—head and neck cancer	0.00305	0.00332	CcSEcCtD
Tolcapone—Decreased appetite—Hydroxyurea—head and neck cancer	0.00302	0.00328	CcSEcCtD
Tolcapone—Abdominal pain—Vinblastine—head and neck cancer	0.00301	0.00327	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.003	0.00326	CcSEcCtD
Tolcapone—Fatigue—Hydroxyurea—head and neck cancer	0.00299	0.00325	CcSEcCtD
Tolcapone—Pain—Hydroxyurea—head and neck cancer	0.00297	0.00323	CcSEcCtD
Tolcapone—Constipation—Hydroxyurea—head and neck cancer	0.00297	0.00323	CcSEcCtD
Tolcapone—Vision blurred—Fluorouracil—head and neck cancer	0.00288	0.00314	CcSEcCtD
Tolcapone—Weight decreased—Docetaxel—head and neck cancer	0.00287	0.00312	CcSEcCtD
Tolcapone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00286	0.00311	CcSEcCtD
Tolcapone—Pneumonia—Docetaxel—head and neck cancer	0.00284	0.00309	CcSEcCtD
Tolcapone—Anaemia—Fluorouracil—head and neck cancer	0.00283	0.00307	CcSEcCtD
Tolcapone—Infestation NOS—Docetaxel—head and neck cancer	0.00283	0.00307	CcSEcCtD
Tolcapone—Infestation—Docetaxel—head and neck cancer	0.00283	0.00307	CcSEcCtD
Tolcapone—Hypersensitivity—Vinblastine—head and neck cancer	0.0028	0.00305	CcSEcCtD
Tolcapone—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00279	0.00303	CcSEcCtD
Tolcapone—Myocardial infarction—Docetaxel—head and neck cancer	0.00277	0.00301	CcSEcCtD
Tolcapone—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00277	0.00301	CcSEcCtD
Tolcapone—Stomatitis—Docetaxel—head and neck cancer	0.00275	0.003	CcSEcCtD
Tolcapone—Body temperature increased—Hydroxyurea—head and neck cancer	0.00274	0.00298	CcSEcCtD
Tolcapone—Asthenia—Vinblastine—head and neck cancer	0.00273	0.00297	CcSEcCtD
Tolcapone—Epistaxis—Docetaxel—head and neck cancer	0.00267	0.0029	CcSEcCtD
Tolcapone—Myalgia—Fluorouracil—head and neck cancer	0.0026	0.00283	CcSEcCtD
Tolcapone—Chest pain—Fluorouracil—head and neck cancer	0.0026	0.00283	CcSEcCtD
Tolcapone—Diarrhoea—Vinblastine—head and neck cancer	0.0026	0.00283	CcSEcCtD
Tolcapone—Discomfort—Fluorouracil—head and neck cancer	0.00257	0.0028	CcSEcCtD
Tolcapone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00256	0.00278	CcSEcCtD
Tolcapone—Haemoglobin—Docetaxel—head and neck cancer	0.00255	0.00277	CcSEcCtD
Tolcapone—Rhinitis—Docetaxel—head and neck cancer	0.00254	0.00277	CcSEcCtD
Tolcapone—Haemorrhage—Docetaxel—head and neck cancer	0.00254	0.00276	CcSEcCtD
Tolcapone—Hypoaesthesia—Docetaxel—head and neck cancer	0.00252	0.00274	CcSEcCtD
Tolcapone—Confusional state—Fluorouracil—head and neck cancer	0.00252	0.00274	CcSEcCtD
Tolcapone—Pharyngitis—Docetaxel—head and neck cancer	0.00252	0.00274	CcSEcCtD
Tolcapone—Dizziness—Vinblastine—head and neck cancer	0.00252	0.00274	CcSEcCtD
Tolcapone—Urinary tract disorder—Docetaxel—head and neck cancer	0.00251	0.00272	CcSEcCtD
Tolcapone—Oedema peripheral—Docetaxel—head and neck cancer	0.0025	0.00272	CcSEcCtD
Tolcapone—Oedema—Fluorouracil—head and neck cancer	0.0025	0.00272	CcSEcCtD
Tolcapone—Asthenia—Hydroxyurea—head and neck cancer	0.00249	0.00271	CcSEcCtD
Tolcapone—Urethral disorder—Docetaxel—head and neck cancer	0.00249	0.0027	CcSEcCtD
Tolcapone—Infection—Fluorouracil—head and neck cancer	0.00248	0.0027	CcSEcCtD
Tolcapone—Nervous system disorder—Fluorouracil—head and neck cancer	0.00245	0.00266	CcSEcCtD
Tolcapone—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00244	0.00266	CcSEcCtD
Tolcapone—Tachycardia—Fluorouracil—head and neck cancer	0.00244	0.00265	CcSEcCtD
Tolcapone—Vomiting—Vinblastine—head and neck cancer	0.00242	0.00263	CcSEcCtD
Tolcapone—Erythema multiforme—Docetaxel—head and neck cancer	0.0024	0.00261	CcSEcCtD
Tolcapone—Headache—Vinblastine—head and neck cancer	0.00238	0.00259	CcSEcCtD
Tolcapone—Anorexia—Fluorouracil—head and neck cancer	0.00238	0.00259	CcSEcCtD
Tolcapone—Diarrhoea—Hydroxyurea—head and neck cancer	0.00237	0.00258	CcSEcCtD
Tolcapone—Hypotension—Fluorouracil—head and neck cancer	0.00233	0.00254	CcSEcCtD
Tolcapone—Angiopathy—Docetaxel—head and neck cancer	0.0023	0.0025	CcSEcCtD
Tolcapone—Dizziness—Hydroxyurea—head and neck cancer	0.00229	0.00249	CcSEcCtD
Tolcapone—Mediastinal disorder—Docetaxel—head and neck cancer	0.00229	0.00249	CcSEcCtD
Tolcapone—Chills—Docetaxel—head and neck cancer	0.00228	0.00248	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00228	0.00247	CcSEcCtD
Tolcapone—Arrhythmia—Docetaxel—head and neck cancer	0.00227	0.00246	CcSEcCtD
Tolcapone—Nausea—Vinblastine—head and neck cancer	0.00226	0.00246	CcSEcCtD
Tolcapone—Paraesthesia—Fluorouracil—head and neck cancer	0.00224	0.00244	CcSEcCtD
Tolcapone—Alopecia—Docetaxel—head and neck cancer	0.00224	0.00244	CcSEcCtD
Tolcapone—Dyspnoea—Fluorouracil—head and neck cancer	0.00223	0.00242	CcSEcCtD
Tolcapone—Mental disorder—Docetaxel—head and neck cancer	0.00222	0.00242	CcSEcCtD
Tolcapone—Somnolence—Fluorouracil—head and neck cancer	0.00222	0.00241	CcSEcCtD
Tolcapone—Vomiting—Hydroxyurea—head and neck cancer	0.00221	0.0024	CcSEcCtD
Tolcapone—Dyspepsia—Fluorouracil—head and neck cancer	0.0022	0.00239	CcSEcCtD
Tolcapone—Rash—Hydroxyurea—head and neck cancer	0.00219	0.00238	CcSEcCtD
Tolcapone—Dermatitis—Hydroxyurea—head and neck cancer	0.00219	0.00238	CcSEcCtD
Tolcapone—Headache—Hydroxyurea—head and neck cancer	0.00217	0.00236	CcSEcCtD
Tolcapone—Decreased appetite—Fluorouracil—head and neck cancer	0.00217	0.00236	CcSEcCtD
Tolcapone—Dysgeusia—Docetaxel—head and neck cancer	0.00216	0.00235	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00216	0.00234	CcSEcCtD
Tolcapone—Pain—Fluorouracil—head and neck cancer	0.00214	0.00232	CcSEcCtD
Tolcapone—Muscle spasms—Docetaxel—head and neck cancer	0.00212	0.00231	CcSEcCtD
Tolcapone—Nausea—Hydroxyurea—head and neck cancer	0.00206	0.00224	CcSEcCtD
Tolcapone—Feeling abnormal—Fluorouracil—head and neck cancer	0.00206	0.00224	CcSEcCtD
Tolcapone—Anaemia—Docetaxel—head and neck cancer	0.00204	0.00222	CcSEcCtD
Tolcapone—Urticaria—Fluorouracil—head and neck cancer	0.00198	0.00216	CcSEcCtD
Tolcapone—Syncope—Docetaxel—head and neck cancer	0.00198	0.00215	CcSEcCtD
Tolcapone—Body temperature increased—Fluorouracil—head and neck cancer	0.00197	0.00215	CcSEcCtD
Tolcapone—Palpitations—Docetaxel—head and neck cancer	0.00195	0.00212	CcSEcCtD
Tolcapone—Loss of consciousness—Docetaxel—head and neck cancer	0.00194	0.00211	CcSEcCtD
Tolcapone—Cough—Docetaxel—head and neck cancer	0.00193	0.0021	CcSEcCtD
Tolcapone—Hypertension—Docetaxel—head and neck cancer	0.00191	0.00207	CcSEcCtD
Tolcapone—Arthralgia—Docetaxel—head and neck cancer	0.00188	0.00204	CcSEcCtD
Tolcapone—Myalgia—Docetaxel—head and neck cancer	0.00188	0.00204	CcSEcCtD
Tolcapone—Chest pain—Docetaxel—head and neck cancer	0.00188	0.00204	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00187	0.00203	CcSEcCtD
Tolcapone—Hypersensitivity—Fluorouracil—head and neck cancer	0.00184	0.002	CcSEcCtD
Tolcapone—Dry mouth—Docetaxel—head and neck cancer	0.00184	0.002	CcSEcCtD
Tolcapone—Confusional state—Docetaxel—head and neck cancer	0.00182	0.00198	CcSEcCtD
Tolcapone—Oedema—Docetaxel—head and neck cancer	0.0018	0.00196	CcSEcCtD
Tolcapone—Infection—Docetaxel—head and neck cancer	0.00179	0.00195	CcSEcCtD
Tolcapone—Shock—Docetaxel—head and neck cancer	0.00177	0.00193	CcSEcCtD
Tolcapone—Nervous system disorder—Docetaxel—head and neck cancer	0.00177	0.00192	CcSEcCtD
Tolcapone—Pruritus—Fluorouracil—head and neck cancer	0.00177	0.00192	CcSEcCtD
Tolcapone—Thrombocytopenia—Docetaxel—head and neck cancer	0.00176	0.00192	CcSEcCtD
Tolcapone—Tachycardia—Docetaxel—head and neck cancer	0.00176	0.00191	CcSEcCtD
Tolcapone—Skin disorder—Docetaxel—head and neck cancer	0.00175	0.0019	CcSEcCtD
Tolcapone—Anorexia—Docetaxel—head and neck cancer	0.00172	0.00187	CcSEcCtD
Tolcapone—Diarrhoea—Fluorouracil—head and neck cancer	0.00171	0.00186	CcSEcCtD
Tolcapone—Hypotension—Docetaxel—head and neck cancer	0.00168	0.00183	CcSEcCtD
Tolcapone—Dizziness—Fluorouracil—head and neck cancer	0.00165	0.0018	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00164	0.00179	CcSEcCtD
Tolcapone—Paraesthesia—Docetaxel—head and neck cancer	0.00162	0.00176	CcSEcCtD
Tolcapone—Dyspnoea—Docetaxel—head and neck cancer	0.00161	0.00175	CcSEcCtD
Tolcapone—Somnolence—Docetaxel—head and neck cancer	0.0016	0.00174	CcSEcCtD
Tolcapone—Vomiting—Fluorouracil—head and neck cancer	0.00159	0.00173	CcSEcCtD
Tolcapone—Dyspepsia—Docetaxel—head and neck cancer	0.00159	0.00173	CcSEcCtD
Tolcapone—Rash—Fluorouracil—head and neck cancer	0.00157	0.00171	CcSEcCtD
Tolcapone—Dermatitis—Fluorouracil—head and neck cancer	0.00157	0.00171	CcSEcCtD
Tolcapone—Decreased appetite—Docetaxel—head and neck cancer	0.00157	0.0017	CcSEcCtD
Tolcapone—Headache—Fluorouracil—head and neck cancer	0.00156	0.0017	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00156	0.00169	CcSEcCtD
Tolcapone—Fatigue—Docetaxel—head and neck cancer	0.00155	0.00169	CcSEcCtD
Tolcapone—Pain—Docetaxel—head and neck cancer	0.00154	0.00168	CcSEcCtD
Tolcapone—Constipation—Docetaxel—head and neck cancer	0.00154	0.00168	CcSEcCtD
Tolcapone—Feeling abnormal—Docetaxel—head and neck cancer	0.00149	0.00161	CcSEcCtD
Tolcapone—Nausea—Fluorouracil—head and neck cancer	0.00148	0.00161	CcSEcCtD
Tolcapone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00147	0.0016	CcSEcCtD
Tolcapone—Abdominal pain—Docetaxel—head and neck cancer	0.00142	0.00155	CcSEcCtD
Tolcapone—Body temperature increased—Docetaxel—head and neck cancer	0.00142	0.00155	CcSEcCtD
Tolcapone—Hypersensitivity—Docetaxel—head and neck cancer	0.00133	0.00144	CcSEcCtD
Tolcapone—Asthenia—Docetaxel—head and neck cancer	0.00129	0.00141	CcSEcCtD
Tolcapone—Pruritus—Docetaxel—head and neck cancer	0.00128	0.00139	CcSEcCtD
Tolcapone—Diarrhoea—Docetaxel—head and neck cancer	0.00123	0.00134	CcSEcCtD
Tolcapone—Dizziness—Docetaxel—head and neck cancer	0.00119	0.0013	CcSEcCtD
Tolcapone—Vomiting—Docetaxel—head and neck cancer	0.00115	0.00125	CcSEcCtD
Tolcapone—Rash—Docetaxel—head and neck cancer	0.00114	0.00124	CcSEcCtD
Tolcapone—Dermatitis—Docetaxel—head and neck cancer	0.00114	0.00123	CcSEcCtD
Tolcapone—Headache—Docetaxel—head and neck cancer	0.00113	0.00123	CcSEcCtD
Tolcapone—Nausea—Docetaxel—head and neck cancer	0.00107	0.00116	CcSEcCtD
